A biotechnology company with a machine learning platform for researching biological compounds.
About
BenchSci is building the world's first neuro-symbolic AI platform, ASCEND, to help scientists understand disease biology and accelerate drug discovery. ASCEND leverages a Biological Evidence Knowledge Graph (BEKG) and advanced AI to provide insights from diverse scientific data, including publications and internal client data. The company serves biopharma R&D teams by transforming how they unravel disease mechanisms and move from hypothesis to successful experiments.
Tags
Total Employees
277
Current headcount
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does BenchSci do?
BenchSci is building the world's first neuro-symbolic AI platform, ASCEND, to help scientists understand disease biology and accelerate drug discovery. ASCEND leverages a Biological Evidence Knowledge Graph (BEKG) and advanced AI to provide insights from diverse scientific data, including publications and internal client data. The company serves biopharma R&D teams by transforming how they unravel disease mechanisms and move from hypothesis to successful experiments.
How much funding has BenchSci raised?
BenchSci has raised a total of $169M in funding. The most recent round on record is Series D.
When was BenchSci founded?
BenchSci was founded in 2015.
How many employees does BenchSci have?
BenchSci has approximately 277 people on record.